At OB Holdings, sustainability is closely tied to how the Group creates long-term value. As a Bursa-listed platform spanning Orient Biotech, Orient Laboratories, and Bonlife, the business links responsible growth with safe and compliant products, certified manufacturing, disciplined governance, and thoughtful capacity expansion. Board-level oversight sits with the Audit and Risk Management Committee, which reviews the Company’s sustainability vision, framework, initiatives, and ESG-aligned disclosures.
At the operational level, the Group’s direction is reflected in its GMP, HACCP, ISO 9001, Halal, and FDA-related quality markers, alongside investments in a new Serendah facility and additional machinery to support more efficient, scalable production. In a trust-driven industry, sustainability at OB Holdings is not separate from performance. It helps protect quality, credibility, and long-term resilience.